Caricamento...
The Current Landscape of Antibody-based Therapies in Solid Malignancies
Over the past three decades, monoclonal antibodies (mAbs) have revolutionized the landscape of cancer therapy. Still, this benefit remains restricted to a small proportion of patients due to moderate response rates and resistance emergence. The field has started to embrace better mAb-based formats w...
Salvato in:
| Pubblicato in: | Theranostics |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ivyspring International Publisher
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7738893/ https://ncbi.nlm.nih.gov/pubmed/33391547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.52614 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|